In vitro activities of new oxazolidinone antimicrobial agents against enterococci

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1745-1747

  Eliopoulos, George M ^a,b   Wennersten, Christine B ^a   Gold, Howard S ^a,b   Moellering Jr , Robert C ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; EPEREZOLID; GENTAMICIN; LINEZOLID; MINOCYCLINE; OXAZOLIDINONE DERIVATIVE; STREPTOMYCIN; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; DRUG ACTIVITY; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

EID: 0029884546     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1745     Document Type: Article

References (18)

1. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571.
2. Barbachyn, M. R., S. J. Brickner, C. W. Ford, S. Glickman, K. C. Grega, S. K. Hendges, J. O. Kilburn, D. S. Toops, D. A. Ulanowicz, and G. E. Zurenko. 1995. Synthesis and structure-activity relationships of new tropone-substituted oxazolidinone antibacterial agents, abstr. F206, p. 141. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Bostic, G., M. B. Perri, L. A. Thal, and M. J. Zervos. 1995. Comparative in-vitro and bactericidal activity of oxazolidinone antibiotics against multidrug resistant enterococci, abstr. F219, p. 151. In Abstracts of the 35th Interscicncc Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, S. A. Garmon, K. C. Grega, S. K. Hendges, P. R. Manninen, D. S. Toops, D. A. Ulanowicz, J. O. Kilburn, S. Glickman, G. E. Zurenko, and C. W. Ford. 1995. Synthesis of U-100592 and U-100766, two new oxazolidinone antibacterial agents in clinical trials for treatment of multiply resistant gram positive infections, abstr. F208, p. 149. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Collins, L. A., G. J. Malanoski, G. M. Eliopoulos, C. B. Wennersten, M. J. Ferraro, and R. C. Moellering, Jr. 1993. In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob. Agents Chemother. 37:598-601.
6. Daly, J. S., G. M. Eliopoulos, E. Reiszner, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro studies of DuP 105 and DuP 721, new oxazolidinone antibacterials. J. Artimicrob. Chemother. 21:721-730.
7. Daly, J. S., G. M. Eliopoulos, S. Willey, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother. 32:1341-1346.
8. Eliopoulos, G. M., C. B. Wennersten, G. Cole, and R. C. Moellering, Jr. 1994. In vitro activities of two glycylcyclines against gram-positive bacteria. Antimicrob. Agents Chemother. 38:534-541.
9. Eliopoulos, G. M., C. B. Wennersten, and R. C. Moellering, Jr. 1995. Activities of new oxazolidinone antimicrobials against enterococci, abstr. F217, p. 151. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Facklam, R. R., and M. D. Collins. 1989. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27:731-734.
11. Gold, H. S., S. Ünal, E. Cercenado, C. Thauvin-Eliopoulos, G. M. Eliopoulos, C. B. Wennersten, and R. C. Moellering, Jr. 1993. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob. Agents Chemother. 37:1604-1609.
12. Handwerger, S., M. J. Pucci, and A. Kolokathis. 1990. Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228. Antimicrob. Agents Chemother. 34:358-360.
13. Hutchinson, D. K., M. R, Barbachyn, S. J. Brickner, J. M. Buysse, W. Demyan, C. W. Ford, G. A. Garmon, S. Glickman, K. C. Grega, S. K. Hendges, J. O. Kilburn, P. R. Manninen, R. J. Reid, D. S. Toops, D. A. Ulanowicz, and G. E. Zurenko. 1995. Piperazinyl oxazolidinones: structure activity relationships of a new class of oxazolidinone antibacterial agents, abstr. F207, p. 149. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1995. In vitro spectrum and activity of U-100592 and U-100766, two novel oxazolidinones, abstr. 209, p. 149. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Moellering, R. C., Jr. 1992. Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis. 14:1173-1178.
16. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial susceptibility testing; fifth informational supplement. NCCLS document M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766. novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.